Kick Back and Relax, We Got Your Synthetic Oligo Workflows Covered

In this presentation, we will present the relevant chromatography, mass spectrometry and spectroscopy based analytical strategies to confidently detect, quantify and purify oligonucleotides and their related impurities that can help you meet both the challenges of synthetic oligonucleotide assessment, and the productivity needs of your lab.

Presenter: Christopher M. Colangelo, PhD, MBA (Biopharma Business Development Leader, Americas, Agilent Technologies, Inc.)

Christopher Colangelo, PhD, MBA is the Agilent Biopharma Business Development Leader for the Americas. Prior to joining Agilent, he was the 5th employee and co-inventor of the 454-sequencing platform. In 2003, Chris joined Yale University as a Research Faculty in where he mentored and supervised a research group producing 60+ peer-reviewed publications and directed core research laboratories for four NIH P30 grants, totaling over $21 million worth of research funds. In 2017, Chris joined Agilent to help customers develop, test, and implement end-to-end biopharma workflows.